Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1953 2
1955 3
1956 2
1957 2
1958 3
1959 2
1960 3
1961 2
1962 7
1963 1
1965 1
1966 2
1967 3
1968 1
1969 1
1970 1
1971 1
1972 3
1977 2
1978 1
1979 1
1980 1
1981 1
1982 4
1983 6
1984 6
1985 4
1986 9
1987 3
1988 3
1989 5
1990 5
1991 9
1992 9
1993 5
1994 2
1995 12
1996 13
1997 16
1998 10
1999 16
2000 14
2001 16
2002 16
2003 22
2004 21
2005 40
2006 46
2007 53
2008 44
2009 38
2010 58
2011 85
2012 78
2013 128
2014 175
2015 172
2016 168
2017 197
2018 209
2019 252
2020 328
2021 338
2022 395
2023 389
2024 456
2025 175

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,657 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK).
Kaye KS, Shorr AF, Wunderink RG, Du B, Poirier GE, Rana K, Miller A, Lewis D, O'Donnell J, Chen L, Reinhart H, Srinivasan S, Isaacs R, Altarac D. Kaye KS, et al. Among authors: du b. Lancet Infect Dis. 2023 Sep;23(9):1072-1084. doi: 10.1016/S1473-3099(23)00184-6. Epub 2023 May 11. Lancet Infect Dis. 2023. PMID: 37182534 Clinical Trial.
Clinical Characteristics of Coronavirus Disease 2019 in China.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Guan WJ, et al. Among authors: du b. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28. N Engl J Med. 2020. PMID: 32109013 Free PMC article.
Lipid metabolism disorder in diabetic kidney disease.
Han YZ, Du BX, Zhu XY, Wang YZ, Zheng HJ, Liu WJ. Han YZ, et al. Among authors: du bx. Front Endocrinol (Lausanne). 2024 Apr 29;15:1336402. doi: 10.3389/fendo.2024.1336402. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38742197 Free PMC article. Review.
A global perspective on vasoactive agents in shock.
Annane D, Ouanes-Besbes L, de Backer D, DU B, Gordon AC, Hernández G, Olsen KM, Osborn TM, Peake S, Russell JA, Cavazzoni SZ. Annane D, et al. Among authors: du b. Intensive Care Med. 2018 Jun;44(6):833-846. doi: 10.1007/s00134-018-5242-5. Epub 2018 Jun 4. Intensive Care Med. 2018. PMID: 29868972 Free article. Review.
COVID-19 as a Trigger for Type 1 Diabetes.
Wang Y, Guo H, Wang G, Zhai J, Du B. Wang Y, et al. Among authors: du b. J Clin Endocrinol Metab. 2023 Aug 18;108(9):2176-2183. doi: 10.1210/clinem/dgad165. J Clin Endocrinol Metab. 2023. PMID: 36950864
3,657 results